GeneCopoeia, Inc. is a US-based manufacturer and provider of genomics and proteomics products and services for
academic and governmental research institutes, pharmaceutical and biotechnology industry. The company is headquartered in the I-270 Hi-Tech corridor in the state of Maryland. Together with investors in China, GeneCopoeia formed a joint venture, FulenGen Co., Ltd. in P.R. China, which has been in operation since 2000.
To become the premier provider of innovative technologies, products, unique tools and services for research discoveries and product development in the areas of biological and biomedical research. Emphasis will be placed on the manufacture and distribution of genomics and proteomics based biological research reagent products of the highest possible quality, which include nucleic acid, protein and antibody based research reagent products and services.
In this way, we serve to assist scientists in academic research institutes, pharmaceutical and biotechnology industries in their pursuit of research discoveries and the development of pharmaceutical and diagnostic products.
GeneCopoeia and its joint venture, FulenGen, have manufactured and released into market the largest number of human full length protein coding ORF cDNA clones in multiple sets of vector systems with various features which make these clones suitable for a variety of functional assays, protein expression and easy purification in many cell types as well as cell free transcription and translation coupling
systems, and large scale functional genomics and proteomics studies. We also offer a comprehensive suite of accurate, reliable and affordable gene and protein based products and services that are integrated with our large collection of full length ORF cDNA clones, which includes recombinant proteins, polyclonal and monoclonal antibodies, RNAi products, custom cloning and protein production services, and other life sciences tools and products.